Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma

Liu, X.; Diekstra, M.H.; Swen, J.J.; E. boven; Castellano, D.; Gelderblom, H.; ... ; Guchelaar, H. (2015)

Article / Letter to editor

• Tyrosine kinase inhibitor
• Sunitinib
• Metastatic renal cell carcinoma
• Single nucleotide polymorphism
• Toxicity
• Progression-free survival

• All authors: Liu, X.; Diekstra, M.H.; Swen, J.J.; E. boven; Castellano, D.; Gelderblom, H.; Mathijssen, R.H.; Rodriguez-Antona, C.; Garcia-Donas, J.; Rini, B.I.; Guchelaar, H.
• Date: 2015-12-31
• Journal: European Journal of Clinical Pharmacology
• Volume: 71
• Issue: 12
• Pages: 1477 - 1484
• DOI: doi:10.1007/s00228-015-1935-7